ly3437943 retatrutide triple agonist glp-1 gip glucagon β±οΈπ How Fast Does Work? What the Clinical Data Shows π¬π Retatrutide is a next-generation triple-agonist therapy targeting GLP-1, GIP, and receptors designed to accelerate fat loss and metabolic improvement Retatrutide 10mg Research Peptide (GLP-1/GIP/Glucagon
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14












:max_bytes(150000):strip_icc()/Health-GettyImages-2155603071-b420bfd333ba4d3c8002df4b51832914.jpg)












